Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Direct ✕Edelweiss Financial Services Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCEdelweiss
NAV₹23.6750₹10.2246
NAV date20 Nov 202620 Nov 2026
History3.1 years9 months
Expense ratio1.1%1.0%
Stars★★★★★Not rated
Growth Score94.50—

Returns

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
1 month+12.97%+12.20%
3 months+7.13%+6.24%
6 months+17.84%+11.05%
YTD+33.73%—
1 year+32.20%—
3 years (CAGR)+30.70%—
5 years (CAGR)——
10 years (CAGR)——
Since launch+31.83%+1.80%

Risk

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
Volatility15.8%—
Downside volatility8.5%—
Sharpe1.53—
Sortino2.86—
Calmar2.06—
Return / risk1.95—
Deepest fall−14.91%−15.82%
Days to recover126235
Below its high+0.00%+0.00%

Against benchmark

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
Alpha+7.54%—
Beta0.97—
R²85.0%—
Up capture108.9%—
Down capture71.0%—
Tracking error6.1%—
Information ratio1.17—
Treynor0.24—

Consistency

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
Best 1-year+67.01%—
Middle 1-year+23.25%—
Worst 1-year+1.71%—
1-year periods with a loss0.0%—
Middle 3-year+30.22%—
Positive months72.2%—
Best day+3.18%+5.24%
Worst day−3.61%−3.47%
Worst 5% day−1.51%−2.07%
Positive days58.3%50.5%
NAVs a year247187

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundEdelweiss Financial Services Fund
5-year XIRR——
5-year value——
3-year XIRR+27.71%—
1-year XIRR+41.37%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth